干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究

崔忠泽; 何双; 温菲菲; 李扬扬; 许晓阳; 路丽祯; 吴淑华

doi:10.19401/j.cnki.1007-3639.2022.12.008

您当前的位置：

首页 >

文章列表页 >

干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究

论著 | 更新时间：2025-12-31

- 干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究
- Experimental study on influence of autophagy on DPD expression and its effect on chemotherapy with 5-FU in colorectal cancer
- 中国癌症杂志 2022年32卷第12期页码：1199-1209
- 作者机构：
  
  滨州医学院附属医院病理科，山东滨州 256600
- 作者简介：
  
  [ "崔忠泽（ORCID: 0000-0003-2145-2156 ）硕士研究生。" ]
  吴淑华（ORCID: 0000-0001-5996-8057 ）硕士研究生导师，教授，主任医师。
- 基金信息：
  
  国家自然科学基金(81772637)
- DOI：10.19401/j.cnki.1007-3639.2022.12.008
  中图分类号： R735.3+4
- 收稿：2022-04-22，
  
  修回：2022-10-17，
  
  纸质出版：2022-12-30
- 稿件说明：
移动端阅览
崔忠泽, 何双, 温菲菲, 等. 干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究[J]. 中国癌症杂志, 2022,32(12):1199-1209.

Zhongze CUI, Shuang HE, Feifei WEN, et al. Experimental study on influence of autophagy on DPD expression and its effect on chemotherapy with 5-FU in colorectal cancer[J]. China Oncology, 2022, 32(12): 1199-1209.
崔忠泽, 何双, 温菲菲, 等. 干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究[J]. 中国癌症杂志, 2022,32(12):1199-1209. DOI： 10.19401/j.cnki.1007-3639.2022.12.008.

Zhongze CUI, Shuang HE, Feifei WEN, et al. Experimental study on influence of autophagy on DPD expression and its effect on chemotherapy with 5-FU in colorectal cancer[J]. China Oncology, 2022, 32(12): 1199-1209. DOI： 10.19401/j.cnki.1007-3639.2022.12.008.

摘要

背景与目的：

结直肠癌作为常见的消化系统恶性肿瘤之一，其化疗与耐药一直以来备受关注，5-氟尿嘧啶（5-fluorouracil，5-FU）是结直肠癌的一线化疗药物，其疗效常因耐药或不良反应而受到影响。二氢嘧啶脱氢酶（dihydropyrimidine dehydrogenase，DPD）是5-FU代谢的关键限速酶，其表达或降解可能成为影响5-FU疗效的因素。自噬是细胞内蛋白质代谢的重要途径，其在化疗诱导的细胞死亡或增殖抑制中的作用仍存在争议。本研究旨在探讨自噬在结直肠癌化疗过程中的作用以及干预自噬影响5-FU耐药的机制。

方法：

体外细胞培养人结肠癌HCT-8、COLO205、LOVO和SW480细胞系，观察不同细胞系中DPD的表达对5-FU敏感性的影响，通过药物敏感性实验筛选出5-FU敏感细胞，检测5-FU敏感细胞株及其相对应的耐药细胞株中DPD的表达、自噬水平及自噬关键因子微管相关蛋白轻链3（light chain 3，LC3）、P62的表达，并通过诱导/抑制细胞自噬，观察调控自噬状态对DPD的表达变化以及肿瘤细胞生物学行为和化疗抵抗能力的影响，通过UbiBrowser数据库筛选及免疫共沉淀实验（co-inmunoprecipitation，Co-IP）实验验证DPD降解过程中的E3连接酶，探讨自噬降解DPD逆转5-FU耐药的分子机制。

结果：

DPD低表达的细胞系对5-FU的敏感性更强，其中COLO205细胞系在4种细胞中DPD表达量最高，并对5-FU的耐药性最强，而HCT-8细胞DPD表达最低并对5-FU最为敏感。与HCT-8细胞相比，HCT-8/FU耐药细胞表达较高水平的DPD，以及较低的基础自噬水平；雷帕霉素（rapamycin，RAPA）介导的自噬激活增强了细胞的自噬水平，降低了DPD表达，同时降低了细胞增殖、侵袭和5-FU耐药性；3甲基腺嘌呤（3-methyladenine，3-MA）及羟氯喹（hydroxychloroquine，HCQ）介导的自噬抑制减弱了细胞的自噬水平，增加了DPD表达，增强了5-FU耐药性。5-FU与自噬激活剂联合应用对细胞的抑效果要远远强于单用5-FU及与自噬抑制剂联合应用的效果；DPD的降解需要完整的自噬流的参与，其中自噬溶酶体的形成是DPD降解的关键步骤之一，而单一的自噬体无法对DPD进行降解。E3连接酶NEDD4在HCT-8/5-FU细胞中与DPD和P62蛋白免疫共沉淀，在DPD的自噬降解中发挥作用。

结论：

自噬参与DPD降解影响结直肠癌细胞对化疗药物的敏感性，激活自噬可促进DPD降解和抑制5-FU的分解代谢，可能成为逆转结直肠癌5-FU耐药的新途径。

Abstract

Background and purpose:

Colorectal cancer is one of the most common digestive system malignancies

and chemotherapy for colorectal cancer and drug resistance have always been concerns. 5-fluorouracil (5-FU) is the first-line chemotherapy drug for colorectal cancer

and its efficacy is often affected by drug resistance or adverse reactions. Dihydropyrimidine dehydrogenase (DPD) is a key rate-limiting enzyme in 5-FU metabolism

and its expression or degradation may be a factor affecting the efficacy of 5-FU. Autophagy is an important pathway of intracellular protein metabolism

and its role in chemotherapy-induced cell death or proliferation inhibition is still controversial. This study aimed to investigate the role of autophagy in colorectal cancer chemot

herapy and the mechanism by which autophagy affects 5-FU drug resistance.

Methods:

Human colon cancer HCT-8

COLO205

LOVO and SW480 cell lines were cultured

in vitro

to observe the effect of DPD expression on 5-FU sensitivity. 5-FU sensitive cells were screened by drug sensitivity test. The expression of DPD

the level of autophagy and the expressions of microtubule-associated protein light chain 3 (LC3) and P62 in 5-FU-sensitive cell lines and their corresponding drug-resistant cell lines were detected. The effect of autophagy on the expression of DPD and the biological behavior and chemotherapy resistance of tumor cells were observed. UbiBrowser database screening and co-inmunoprecipitationn (Co-IP) experiment were used to verify the E3 ligase in the process of DPD degradation

and to investigate the molecular mechanism of reversing 5-FU resistance caused by autophagy degradation of DPD.

Results:

The COLO205 cell line had the highest DPD expression and was the most resistant to 5-FU

while the HCT-8 cell line had the lowest DPD expression and was the most sensitive to 5-FU. Compared with HCT-8/5-FU cells

HCT-8/FU-resistant cells expressed higher levels of DPD and lower levels of basal autophagy. Rapamycin (RAPA)-mediated autophagy activation enhanced the autophagy level

decreased the expression of DPD

and decreased cell proliferation

invasion and 5-FU resistance. The inhibition of autophagy mediated by 3-Methyladenine (3-MA) and hydroxychloroquine (HCQ) attenuated the autophagy level

increased the expression of DPD

and enhanced the drug resistance of 5-FU. The inhibitory effect of 5-FU combined with autophagy activator was much stronger compared with 5-FU alone or combined with autophagy inhibitor. The degradation of DPD required the participation of complete autophagic flow

among which the formation of autophagic lysosomes was one of the key steps of DPD degradation

however a single autophagosome could not degrade DPD. E3 ligase NEDD4 co-immunoprecipitated wi

th DPD and P62 proteins in HCT-8/5-FU cells and played a role in autophagic degradation of DPD.

Conclusion:

The involvement of autophagy in DPD degradation affects the sensitivity of colorectal cancer cells to chemotherapy drugs. Activation of autophagy can promote the degradation of DPD and inhibit the catabolism of 5-FU

which may be a new way to reverse 5-FU resistance in colorectal cancer.

关键词

Keywords

references

PATEL S G , KARLITZ J J , YEN T , et al . The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection [J ] . Lancet Gastroenterol Hepatol , 2022 , 7 ( 3 ): 262 - 274 . DOI: 10.1016/S2468-1253(21)00426-X http://doi.org/10.1016/S2468-1253(21)00426-X https://linkinghub.elsevier.com/retrieve/pii/S246812532100426X https://linkinghub.elsevier.com/retrieve/pii/S246812532100426X

BENSON A B , VENOOK A P , AL-HAWARY M M , et al . NCCN guidelines insights: colon cancer, version 2.2018 [J ] . J Natl Compr Canc Netw , 2018 , 16 ( 4 ): 359 - 369 . DOI: 10.6004/jnccn.2018.0021 http://doi.org/10.6004/jnccn.2018.0021 https://jnccn.org/doi/10.6004/jnccn.2018.0021 https://jnccn.org/doi/10.6004/jnccn.2018.0021

MALIER M , GHARZEDDINE K , LAVERRIERE M H , et al . Hypoxia drives dihydropyrimidine dehydrogenase expression in macrophages and confers chemoresistance in colorectal cancer [J ] . Cancer Res , 2021 , 81 ( 23 ): 5963 - 5976 . DOI: 10.1158/0008-5472.CAN-21-1572 http://doi.org/10.1158/0008-5472.CAN-21-1572

DE FALCO V , NATALICCHIO M I , NAPOLITANO S , et al . A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant [J ] . Medicine , 2019 , 98 ( 21 ): e15759.

DEAN L , KANE M . Fluorouracil therapy and DPYD genotype [M ] . PRATT V M, SCOTT S A, PIRMOHAMED M, eds. Medical genetics summaries. . Bethesda (MD) : National Center for Biotechnology Information (US) ; November 3, 2016 .

贾真真 , 何双 , 李扬扬 , 等 . 结直肠癌中DPD与LC3、P62表达的相关性及其临床意义 [J ] . 中国癌症杂志 , 2022 , 32 ( 1 ): 24 - 33 . DOI: 10.19401/j.cnki.1007-3639.2022.01.003 http://doi.org/10.19401/j.cnki.1007-3639.2022.01.003

JIA Z Z , HE S , LI Y Y , et al . Correlations between expressions of DPD, LC3 and P62 in colorectal cancer and their clinical significance [J ] . China Oncol , 2022 , 32 ( 1 ): 24 - 33 .

YU L , CHEN Y , TOOZE S A . Autophagy pathway: cellular and molecular mechanisms [J ] . Autophagy , 2018 , 14 ( 2 ): 207 - 215 . DOI: 10.1080/15548627.2017.1378838 http://doi.org/10.1080/15548627.2017.1378838

DIKIC I , ELAZAR Z . Mechanism and medical implications of mammalian autophagy [J ] . Nat Rev Mol Cell Biol , 2018 , 19 ( 6 ): 349 - 364 . DOI: 10.1038/s41580-018-0003-4 http://doi.org/10.1038/s41580-018-0003-4 https://doi.org/10.1038/s41580-018-0003-4 https://doi.org/10.1038/s41580-018-0003-4

ISLAM M A , SOORO M A , ZHANG P H . Autophagic regulation of p62 is critical for cancer therapy [J ] . Int J Mol Sci , 2018 , 19 ( 5 ): 1405 . DOI: 10.3390/ijms19051405 http://doi.org/10.3390/ijms19051405 http://www.mdpi.com/1422-0067/19/5/1405 http://www.mdpi.com/1422-0067/19/5/1405

JIN H , SEO G S , LEE S H . Isoliquiritigenin-mediated p62/SQSTM1 induction regulates apoptotic potential through attenuation of caspase-8 activation in colorectal cancer cells [J ] . Eur J Pharmacol , 2018 , 841 : 90 - 97 . DOI: S0014-2999(18)30591-0 http://doi.org/S0014-2999(18)30591-0

LAMARK T , SVENNING S , JOHANSEN T . Regulation of selective autophagy: the p62/SQSTM1 paradigm [J ] . Essays Biochem , 2017 , 61 ( 6 ): 609 - 624 . DOI: 10.1042/EBC20170035 http://doi.org/10.1042/EBC20170035

SUN A Q , WEI J , CHILDRESS C , et al . The E3 ubiquitin ligase NEDD4 is an LC3-interactive protein and regulates autophagy [J ] . Autophagy , 2017 , 13 ( 3 ): 522 - 537 . DOI: 10.1080/15548627.2016.1268301 http://doi.org/10.1080/15548627.2016.1268301

LEVINE B , KROEMER G . Biological functions of autophagy genes: a disease perspective [J ] . Cell , 2019 , 176 ( 1/2 ): 11 - 42 . DOI: 10.1016/j.cell.2018.09.048 http://doi.org/10.1016/j.cell.2018.09.048 https://linkinghub.elsevier.com/retrieve/pii/S0092867418312601 https://linkinghub.elsevier.com/retrieve/pii/S0092867418312601

BONAM S R , TRANCHANT C , MULLER S . Autophagy-lysosomal pathway as potential therapeutic target in Parkinson's disease [J ] . Cells , 2021 , 10 ( 12 ): 3547 . DOI: 10.3390/cells10123547 http://doi.org/10.3390/cells10123547 https://www.mdpi.com/2073-4409/10/12/3547 https://www.mdpi.com/2073-4409/10/12/3547

YANG Y , WANG Q , SONG D J , et al . Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway [J ] . J Exp Clin Cancer Res , 2020 , 39 ( 1 ): 197 . DOI: 10.1186/s13046-020-01701-z http://doi.org/10.1186/s13046-020-01701-z https://doi.org/10.1186/s13046-020-01701-z https://doi.org/10.1186/s13046-020-01701-z

LI J X , LIU G , LI L , et al . Research progress on the effect of autophagy-lysosomal pathway on tumor drug resistance [J ] . Exp Cell Res , 2020 , 389 ( 2 ): 111925.

XUAN Y , ZHAO S , XIAO X J , et al . Inhibition of chaperone-mediated autophagy reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer [J ] . Mol Med Rep , 2021 , 23 ( 5 ): 360 . DOI: 10.3892/mmr.2021.11999 http://doi.org/10.3892/mmr.2021.11999 http://www.spandidos-publications.com/10.3892/mmr.2021.11999 http://www.spandidos-publications.com/10.3892/mmr.2021.11999

YANG J W , ZHANG Q H , LIU T . Autophagy facilitates anticancer effect of 5-fluorouracil in HCT-116 cells [J ] . J Cancer Res Ther , 2018 , 14 ( Supplement ): S1141-S1147.

TOZER T , HEALE K , MANTO CHAGAS C , et al . Interdomain twists of human thymidine phosphorylase and its active-inactive conformations: binding of 5-FU and its analogues to human thymidine phosphorylase versus dihydropyrimidine dehydrogenase [J ] . Chem Biol Drug Des , 2019 , 94 ( 5 ): 1956 - 1972 . DOI: 10.1111/cbdd.13596 http://doi.org/10.1111/cbdd.13596

SHARMA V , GUPTA S K , VERMA M . Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs [J ] . Cancer Chemother Pharmacol , 2019 , 84 ( 6 ): 1157 - 1166 . DOI: 10.1007/s00280-019-03936-w http://doi.org/10.1007/s00280-019-03936-w https://doi.org/10.1007/s00280-019-03936-w https://doi.org/10.1007/s00280-019-03936-w

ZHANG Y H , SHI W N , WU S H , et al . SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression [J ] . Oncogene , 2020 , 39 ( 29 ): 5214 - 5227 . DOI: 10.1038/s41388-020-1352-y http://doi.org/10.1038/s41388-020-1352-y https://doi.org/10.1038/s41388-020-1352-y https://doi.org/10.1038/s41388-020-1352-y

ZHANG Y H , LUO D D , WAN S B , et al . S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer [J ] . Pharmacol Res , 2020 , 155 : 104717.

YOSHII S R , MIZUSHIMA N . Monitoring and measuring autophagy [J ] . Int J Mol Sci , 2017 , 18 ( 9 ): 1865 . DOI: 10.3390/ijms18091865 http://doi.org/10.3390/ijms18091865 http://www.mdpi.com/1422-0067/18/9/1865 http://www.mdpi.com/1422-0067/18/9/1865

OZATES N P , SOĞUTLU F , LERMINOGLU F , et al . Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer [J ] . Life Sci , 2021 , 264 : 118643.

ZHANG J , MAO W , LIU Y Y , et al . 3-MA enhanced chemosensitivity in cisplatin resistant hypopharyngeal squamous carcinoma cells via inhibiting beclin-1 mediated autophagy [J ] . Curr Pharm Des , 2021 , 27 ( 7 ): 996 - 1005 . DOI: 10.2174/1381612826666201221150431 http://doi.org/10.2174/1381612826666201221150431 https://www.eurekaselect.com/189311/article https://www.eurekaselect.com/189311/article

LIU L Q , WANG S B , SHAO Y F , et al . Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy [J ] . Biomedecine Pharmacother , 2019 , 118 : 109339.

ZAMAME RAMIREZ J A , ROMAGNOLI G G , KANENO R . Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy [J ] . Life Sci , 2021 , 265 : 118745.

LI J , HOU N , FARIED A , et al . Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model [J ] . Eur J Cancer , 2010 , 46 ( 10 ): 1900 - 1909 . DOI: 10.1016/j.ejca.2010.02.021 http://doi.org/10.1016/j.ejca.2010.02.021

CHOI J H , YOON J S , WON Y W , et al . Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration [J ] . APMIS , 2012 , 120 ( 7 ): 597 - 604 . DOI: 10.1111/j.1600-0463.2012.02876.x http://doi.org/10.1111/j.1600-0463.2012.02876.x https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0463.2012.02876.x https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0463.2012.02876.x

LIU W J , YE L , HUANG W F , et al . p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation [J ] . Cell Mol Biol Lett , 2016 , 21 : 29 . DOI: 10.1186/s11658-016-0031-z http://doi.org/10.1186/s11658-016-0031-z

JOHANSEN T , LAMARK T . Selective autophagy mediated by autophagic adapter proteins [J ] . Autophagy , 2011 , 7 ( 3 ): 279 - 296 . DOI: 10.4161/auto.7.3.14487 http://doi.org/10.4161/auto.7.3.14487

ZHENG N , SHABEK N . Ubiquitin ligases: Structure, function, and regulation [J ] . Annu Rev Biochem , 2017 , 86 : 129 - 157 . DOI: 10.1146/annurev-biochem-060815-014922 http://doi.org/10.1146/annurev-biochem-060815-014922

浏览量

1160

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

结直肠癌中DPD与LC3、P62表达的相关性及其临床意义

结直肠癌中LC3与树突状细胞募集、TLS形成的相关性及其临床意义

端粒酶抑制剂BIBR1532联合自噬抑制剂CQ抑制黑色素瘤细胞生存的机制研究

uPAR通过MAPK信号抑制细胞自噬促进胰腺癌增殖、侵袭及化疗抵抗的作用研究

乳腺癌中心体调控蛋白SEC23B在肿瘤浸润转移中的作用及其机制研究